{
  "id": "6025fdf41cb411341a0000c0",
  "type": "yesno",
  "question": "Should nerinetide be used for treatment of ischaemic stroke?",
  "ideal_answer": "Nerinetide did not improve the proportion of ischemic stroke patients achieving good clinical outcomes after endovascular thrombectomy compared with patients receiving placebo.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/32087818",
    "http://www.ncbi.nlm.nih.gov/pubmed/33148815"
  ],
  "snippets": [
    {
      "text": "337 (61\u00b74%) of 549 patients with nerinetide and 329 (59\u00b72%) of 556 with placebo achieved an mRS score of 0-2 at 90 days (adjusted risk ratio 1\u00b704, 95% CI 0\u00b796-1\u00b714; p=0\u00b735). Secondary outcomes were similar between groups.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32087818",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "INTERPRETATION: Nerinetide did not improve the proportion of patients achieving good clinical outcomes after endovascular thrombectomy compared with patients receiving placebo.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32087818",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}